• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母源抗体可抵御H7N3亚型高致病性禽流感病毒的攻击。

Maternally-Derived Antibodies Protect against Challenge with Highly Pathogenic Avian Influenza Virus of the H7N3 Subtype.

作者信息

Cardenas-Garcia Stivalis, Ferreri Lucas, Wan Zhimin, Carnaccini Silvia, Geiger Ginger, Obadan Adebimpe O, Hofacre Charles L, Rajao Daniela, Perez Daniel R

机构信息

Department of Population Health, University of Georgia, Poultry Diagnostic and Research Center, Athens, GA 30602, USA.

Southern Poultry Research Group, Watkinsville, GA 30677, USA.

出版信息

Vaccines (Basel). 2019 Oct 30;7(4):163. doi: 10.3390/vaccines7040163.

DOI:10.3390/vaccines7040163
PMID:31671571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6963706/
Abstract

Vaccination of hens against influenza leads to the transfer of protective maternally-derived antibodies (MDA) to hatchlings. However, little is known about the transfer of H7N3 vaccine-induced MDA. Here, we evaluated transfer, duration, and protective effect of MDA in chickens against H7N3 HPAIV. To generate chickens with MDA (MDA (+)), 15-week-old White Leghorn hens were vaccinated and boosted twice with an inactivated H7N3 low pathogenic avian influenza virus vaccine, adjuvanted with Montanide ISA 71 VG. One week after the final boost, eggs were hatched. Eggs from non-vaccinated hens were hatched for chickens without MDA (MDA (-)). Both MDA (+) and MDA (-) hatchlings were monitored weekly for antibody levels. Anti-HA MDA were detected by hemagglutination inhibition assay mostly until day 7 post-hatch. However, anti-nucleoprotein MDA were still detected three weeks post-hatch. Three weeks post-hatch, chickens were challenged with 10 EID/bird of Mexican-origin H7N3 HPAIV. Interestingly, while 0% of the MDA (-) chickens survived the challenge, 95% of the MDA (+) chickens survived. Furthermore, virus shedding was significantly reduced by day 5 post-challenge in the MDA (+) group. In conclusion, MDA confers partial protection against mortality upon challenge with H7N3 HPAIV, as far as three weeks post-hatch, even in the absence of detectable anti-HA antibodies, and reduce virus shedding after challenge.

摘要

给母鸡接种流感疫苗可导致保护性母源抗体(MDA)传递给雏鸡。然而,关于H7N3疫苗诱导的MDA的传递情况却知之甚少。在此,我们评估了鸡体内MDA针对H7N3高致病性禽流感病毒(HPAIV)的传递、持续时间及保护效果。为培育具有MDA的鸡(MDA(+)),对15周龄的白来航母鸡接种并用Montanide ISA 71 VG佐剂的灭活H7N3低致病性禽流感病毒疫苗进行两次加强免疫。最后一次加强免疫一周后,孵化鸡蛋。将未接种疫苗的母鸡所产鸡蛋孵化用于培育无MDA的鸡(MDA(-))。每周监测MDA(+)和MDA(-)雏鸡的抗体水平。通过血凝抑制试验检测抗血凝素(HA)MDA,大多在雏鸡出壳后第7天可检测到。然而,抗核蛋白MDA在出壳后三周仍可检测到。出壳后三周,用每只10个鸡胚感染剂量(EID)的墨西哥源H7N3 HPAIV对鸡进行攻毒。有趣的是,MDA(-)组鸡在攻毒后0%存活,而MDA(+)组鸡95%存活。此外,MDA(+)组在攻毒后第5天病毒排泄显著减少。总之,MDA在雏鸡出壳后长达三周的时间里,即使在未检测到抗HA抗体的情况下,也能对H7N3 HPAIV攻毒提供部分保护作用,减少攻毒后的病毒排泄。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/6963706/ce9cb4d7a9c9/vaccines-07-00163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/6963706/24a00c2a30eb/vaccines-07-00163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/6963706/9da8d876fc28/vaccines-07-00163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/6963706/b2077cd01a14/vaccines-07-00163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/6963706/ce9cb4d7a9c9/vaccines-07-00163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/6963706/24a00c2a30eb/vaccines-07-00163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/6963706/9da8d876fc28/vaccines-07-00163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/6963706/b2077cd01a14/vaccines-07-00163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f39/6963706/ce9cb4d7a9c9/vaccines-07-00163-g004.jpg

相似文献

1
Maternally-Derived Antibodies Protect against Challenge with Highly Pathogenic Avian Influenza Virus of the H7N3 Subtype.母源抗体可抵御H7N3亚型高致病性禽流感病毒的攻击。
Vaccines (Basel). 2019 Oct 30;7(4):163. doi: 10.3390/vaccines7040163.
2
Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.新型重组禽痘疫苗对近期墨西哥 H7N3 高致病性禽流感病毒的效力。
Vaccine. 2019 Apr 10;37(16):2232-2243. doi: 10.1016/j.vaccine.2019.03.009. Epub 2019 Mar 15.
3
Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.母源抗体对鸡用重组新城疫病毒载体疫苗在肉鸡基础免疫或加强免疫禽流感疫苗程序中的抑制作用。
Vaccine. 2018 Oct 15;36(43):6361-6372. doi: 10.1016/j.vaccine.2018.09.015. Epub 2018 Sep 18.
4
Protection afforded by avian influenza vaccination programmes consisting of a novel RNA particle and an inactivated avian influenza vaccine against a highly pathogenic avian influenza virus challenge in layer chickens up to 18 weeks post-vaccination.新型 RNA 颗粒和灭活禽流感疫苗组成的禽流感疫苗接种方案对 18 周龄产蛋鸡接种高致病性禽流感病毒的保护作用。
Avian Pathol. 2019 Aug;48(4):371-381. doi: 10.1080/03079457.2019.1605148. Epub 2019 May 20.
5
Protection of Chickens with Maternal Immunity Against Avian Influenza Virus (AIV) by Vaccination with a Novel Recombinant Newcastle Disease Virus Vector.用新型重组新城疫病毒载体疫苗对鸡进行母源免疫保护以抵抗禽流感病毒(AIV)。
Avian Dis. 2020 Dec 1;64(4):427-436. doi: 10.1637/aviandiseases-D-20-00014.
6
Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines.用重组鸡痘病毒和灭活禽流感疫苗免疫的鸡对H7N3高致病性禽流感的保护作用。
Vaccine. 2013 Aug 2;31(35):3572-6. doi: 10.1016/j.vaccine.2013.05.039. Epub 2013 May 23.
7
Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.用于鸡用高致病性禽流感病毒疫苗的10种不同佐剂的免疫学评估。
Vaccine. 2017 Jun 8;35(26):3401-3408. doi: 10.1016/j.vaccine.2017.05.010. Epub 2017 May 13.
8
Potency, efficacy, and antigenic mapping of H7 avian influenza virus vaccines against the 2012 H7N3 highly pathogenic avian influenza virus from Mexico.针对来自墨西哥的2012年H7N3高致病性禽流感病毒的H7禽流感病毒疫苗的效力、效果及抗原图谱分析
Avian Dis. 2014 Sep;58(3):359-66. doi: 10.1637/10751-121913-Reg.1.
9
Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny.母源抗体在鸡中提供的被动保护以及这些抗体对后代中禽流感灭活疫苗引发的保护作用的干扰。
Avian Dis. 2010 Mar;54(1 Suppl):246-52. doi: 10.1637/8908-043009-Reg.1.
10
Reduction of high pathogenicity avian influenza virus in eggs from chickens once or twice vaccinated with an oil-emulsified inactivated H5 avian influenza vaccine.一次或两次接种油乳剂灭活 H5 禽流感疫苗后鸡鸡蛋中高致病性禽流感病毒的减少。
Vaccine. 2012 Jul 13;30(33):4964-70. doi: 10.1016/j.vaccine.2012.05.041. Epub 2012 May 29.

引用本文的文献

1
The Generation of a H9N2 Avian Influenza Virus with HA and C3d-P29 Protein Fusions and Vaccine Development Applications.具有HA与C3d-P29蛋白融合的H9N2禽流感病毒的产生及疫苗开发应用
Vaccines (Basel). 2025 Jan 21;13(2):99. doi: 10.3390/vaccines13020099.
2
Mass vaccination with reassortment-impaired live H9N2 avian influenza vaccine.使用重配缺陷型H9N2禽流感活疫苗进行大规模接种。
NPJ Vaccines. 2024 Aug 3;9(1):136. doi: 10.1038/s41541-024-00923-y.
3
Attenuation and molecular characterization of fowl adenovirus 8b propagated in a bioreactor and its immunogenicity, efficacy, and virus shedding in broiler chickens.

本文引用的文献

1
Loss of Fitness of Mexican H7N3 Highly Pathogenic Avian Influenza Virus in Mallards after Circulating in Chickens.在鸡中循环传播后,墨西哥 H7N3 高致病性禽流感病毒对野鸭的适应性降低。
J Virol. 2019 Jun 28;93(14). doi: 10.1128/JVI.00543-19. Print 2019 Jul 15.
2
Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.新型重组禽痘疫苗对近期墨西哥 H7N3 高致病性禽流感病毒的效力。
Vaccine. 2019 Apr 10;37(16):2232-2243. doi: 10.1016/j.vaccine.2019.03.009. Epub 2019 Mar 15.
3
Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans.
在生物反应器中增殖的禽腺病毒8b的致弱、分子特性及其在肉鸡中的免疫原性、效力和病毒排出情况
Vet World. 2024 Apr;17(4):744-755. doi: 10.14202/vetworld.2024.744-755. Epub 2024 Apr 3.
4
Antigenic mapping of the hemagglutinin of the H9 subtype influenza A viruses using sera from Japanese quail ().使用来自鹌鹑()的血清对 H9 亚型流感 A 病毒的血凝素进行抗原作图。
J Virol. 2023 Oct 31;97(10):e0074323. doi: 10.1128/jvi.00743-23. Epub 2023 Oct 6.
5
Assessment of an Enterobactin Conjugate Vaccine in Layers to Protect Their Offspring from Colibacillosis.评估一种肠杆菌素缀合物疫苗在蛋鸡中的应用,以保护其后代免受大肠杆菌病的侵害。
Pathogens. 2023 Jul 31;12(8):1002. doi: 10.3390/pathogens12081002.
6
Haemagglutinin antigen selectively targeted to chicken CD83 overcomes interference from maternally derived antibodies in chickens.选择性靶向鸡CD83的血凝素抗原克服了母源抗体对鸡的干扰。
NPJ Vaccines. 2022 Mar 3;7(1):33. doi: 10.1038/s41541-022-00448-2.
评估 H1N1 流感病毒血凝素头部和茎部抗体在人体中的保护潜力。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02134-18. Print 2019 Apr 15.
4
Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.母源抗体对鸡用重组新城疫病毒载体疫苗在肉鸡基础免疫或加强免疫禽流感疫苗程序中的抑制作用。
Vaccine. 2018 Oct 15;36(43):6361-6372. doi: 10.1016/j.vaccine.2018.09.015. Epub 2018 Sep 18.
5
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.人类流感感染诱导广泛交叉反应和保护性神经氨酸酶反应性抗体。
Cell. 2018 Apr 5;173(2):417-429.e10. doi: 10.1016/j.cell.2018.03.030.
6
Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.减毒活疫苗和灭活疫苗对小鸡的疗效和协同作用。
PLoS One. 2018 Apr 6;13(4):e0195285. doi: 10.1371/journal.pone.0195285. eCollection 2018.
7
Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.评估健康志愿者挑战甲型流感病毒 A/H1N1pdm 时预先存在的抗血凝素茎部抗体作为保护相关性。
mBio. 2018 Jan 23;9(1):e02284-17. doi: 10.1128/mBio.02284-17.
8
Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.灭活H7流感病毒疫苗尽管仅诱导产生低水平的中和抗体,但仍可保护小鼠。
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.01202-17. Print 2017 Oct 15.
9
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Outflanking Antibody Immunodominance on the Road to Universal Influenza Vaccination.是否有可能开发出“通用”流感病毒疫苗?在通往通用流感疫苗的道路上规避抗体免疫优势。
Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7):a028852. doi: 10.1101/cshperspect.a028852.
10
Plasmid-Based Reverse Genetics of Influenza A Virus.基于质粒的甲型流感病毒反向遗传学
Methods Mol Biol. 2017;1602:251-273. doi: 10.1007/978-1-4939-6964-7_16.